1. Home
  2. META vs NVO Comparison

META vs NVO Comparison

Compare META & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meta Platforms Inc.

META

Meta Platforms Inc.

HOLD

Current Price

$592.96

Market Cap

1.4T

Sector

Technology

ML Signal

HOLD

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$47.21

Market Cap

208.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
META
NVO
Founded
2004
1923
Country
United States
Denmark
Employees
N/A
69500
Industry
Computer Software: Programming Data Processing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4T
208.2B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
META
NVO
Price
$592.96
$47.21
Analyst Decision
Strong Buy
Hold
Analyst Count
40
11
Target Price
$838.63
$51.00
AVG Volume (30 Days)
14.3M
11.2M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
0.31%
3.19%
EPS Growth
N/A
N/A
EPS
10.44
N/A
Revenue
$40,653,000,000.00
N/A
Revenue This Year
$26.99
N/A
Revenue Next Year
$18.21
$3.70
P/E Ratio
$56.69
$13.60
Revenue Growth
47.09
N/A
52 Week Low
$520.26
$35.12
52 Week High
$796.25
$64.16

Technical Indicators

Market Signals
Indicator
META
NVO
Relative Strength Index (RSI) 47.21 41.94
Support Level $583.79 $45.62
Resistance Level $615.40 $46.92
Average True Range (ATR) 18.09 1.40
MACD -3.70 -0.73
Stochastic Oscillator 49.86 25.13

Price Performance

Historical Comparison
META
NVO

About META Meta Platforms Inc.

Meta is the largest social media company in the world, boasting close to 4 billion monthly active users worldwide. The firm's "Family of Apps," its core business, consists of Facebook, Instagram, Messenger, and WhatsApp. End users can leverage these applications for a variety of different purposes, from keeping in touch with friends to following celebrities and running digital businesses for free. Meta packages customer data, gleaned from its application ecosystem and sells ads to digital advertisers. While the firm has been investing heavily in its Reality Labs business, it remains a very small part of Meta's overall sales.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: